Jemima A. Frimpong, PhD

Jemima A. Frimpong, PhD

Associate Professor

Academic Discipline: Management & Organization

Areas of Interest: Health Care Organizations, Organizational Behavior, Decision-making


Phone: 410-234-9246

Email: jafrimpong@jhu.edu

Biography

Jemima A. Frimpong, PhD (Management Science and Applied Economics, The Wharton School at the University of Pennsylvania) is an Associate Professor at the Carey Business School. She is also a faculty member of the Armstrong Institute for Patient Safety and Quality at the School of Medicine. Before joining Johns Hopkins University, she was on the faculty of Columbia University. Dr. Frimpong has two main areas of research: 1) the adoption and sustainability of innovations in health care organizations; and 2) the complex processes leading to discrimination in labor markets. Her work uses a broad array of methods, ranging from in-depth interviews, to randomized trials and functional imaging.

Dr. Frimpong has investigated the diffusion of new diagnostics (e.g., rapid Hepatitis C virus testing) in healthcare facilities offering treatment for opioid addiction. She is the principal investigator of several NIH-funded randomized trials testing new strategies to improve services provided at opioid treatment programs across the US. She is also conducting a series of experiments designed to elicit the neural correlates of implicit bias in hiring decisions, using functional magnetic resonance imaging (fMRI).

Honors & Distinctions

  • National Institute of Health research award (R01DA043130), 2016 -2021
  • Johns Hopkins University Provost Catalyst Award, 2017
  • National Institute of Health research award (R34DA038530), 2014 - 2018
  • Kirschstein National Research Service Award, 2007 - 2009
  • Wharton Center for International Business Education and Research (CIBER), 2007

Selected Publications

  • Guerrero, E.G., Frimpong, J.A., Kong Y. (2018). “Advancing Theory on the Multilevel Role of Leadership in the Implementation of Evidence-Based Health Care Practices.” Health Care Management Review.         
  • Frimpong J.A., Myers C.G., Sutcliffe K.G., Lu-Myers Y., (2017) “When Health Care Providers Look at Problems from Multiple Perspectives, Patients Benefit.” Harvard Business Review.
  • Lucero, R.J, Frimpong, J.A., Fehlberg, E.A., Bjarnadottir, R.I., Weaver, M.T., Cook, C., Modave, F., Rathore, M.H., Morano, J.P., Ibanez, G., Cook, R.L. (2017) “The Relationship Between Individual Characteristics and Interest in Using a Mobile Phone App for HIV Self-management: Observational Cohort Study of People Living with HIV.” Journal of Medical Internet Research.
  • Frimpong J.A., Shiu-Yee K., D’Aunno T. (2016). “The Role of Program Directors in Treatment Practices: The Case of Methadone Dose Patterns in U.S. Outpatient Opioid Agonist Treatment Programs.” Health Services Research.
  • Frimpong, J.A., D’Aunno T. (2016). “Hepatitis C Testing in Substance Use Disorder Treatment: The Role of Program Managers in Adoption of Testing Services.” Substance Abuse Treatment, Prevention, and Policy.
  • Frimpong, J.A., D'Aunno, T., Feaster, D., Metsch, L., Perlman, D., Struass, S., Hernandez, D., Mallow, A., Schackman, B. (2016). “On-site bundled rapid HIV/HCV testing in substance use disorder treatment programs: Study protocol for a hybrid design randomized controlled trial.” Trials.
  • Frimpong J.A., D’Aunno T., Helleringer S., Metsch L. (2016) “Low Rates of Adoption and Implementation of Rapid HIV Testing in Substance Use Disorder Treatment Programs.” Journal of Substance Abuse Treatment.
  • D’Aunno T., Pollack, H., Frimpong J.A., Wutchiett DM. (2014) “Evidence-based treatment for opioid disorders: A 23-year nation study of methadone dose levels.” Journal of Substance Abuse Treatment.
  • Frimpong, J.A., D’Aunno T., Jiang, L. (2014) “Determinants of the Availability of Hepatitis C Testing Services in Opioid Treatment Programs: Results from a National Study.” American Journal of Public Health.
  • Frimpong J.A. (2013) “Missed opportunities for Hepatitis-C testing in outpatient substance abuse treatment programs.” American Journal of Public Health.